檢索結果 - Wang-Gillam, Andrea

Entering the molecular era of gastrointestinal oncology: current updates and challenges 由 Wang-Gillam, Andrea, Lim, Kian-Huat

獲取全文 獲取全文 獲取全文

Promising therapeutics of gastrointestinal cancers in clinical trials 由 Du, Lingling, Che, Zheng, Wang-Gillam, Andrea

獲取全文 獲取全文 獲取全文

Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies 由 Teague, Andrea, Lim, Kian-Huat, Wang-Gillam, Andrea

獲取全文 獲取全文 獲取全文

Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma 由 So, Eiichiro, Crees, Zachary D., Crites, Danielle, Wang-Gillam, Andrea

獲取全文 獲取全文 獲取全文

Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma 由 Peddi, Parvin F., Cho, May, Wang, Jian, Gao, Feng, Wang-Gillam, Andrea

獲取全文 獲取全文 獲取全文

Racial Disparities in the Outcomes of Patients With Stage IV Pancreatic Adenocarcinoma are Mediated by Chemotherapy Utilization 由 Atkins, Jordan J., Fiala, Mark A., Wang-Gillam, Andrea, Wildes, Tanya M.

獲取全文 獲取全文 獲取全文

Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature 由 How, Joan, Blattner, Margaret, Fowler, Susan, Wang-Gillam, Andrea, Schindler, Suzanne E

獲取全文 獲取全文 獲取全文

Neoadjuvant Therapy of Pancreatic Cancer: The Emerging Paradigm? 由 Lim, Kian-Huat, Chung, Eugene, Khan, Adeel, Cao, Dengfeng, Linehan, David, Ben-Josef, Edgar, Wang-Gillam, Andrea

獲取全文 獲取全文 獲取全文

Phase II Trial of Gemcitabine and Tanespimycin (17AAG) in Metastatic Pancreatic Cancer: A Mayo Clinic Phase II Consortium Study 由 Pedersen, Katrina S., Kim, George P., Foster, Nathan R., Wang-Gillam, Andrea, Erlichman, Charles, McWilliams, Robert R.

獲取全文 獲取全文 獲取全文

Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma 由 Cho, May, Peddi, Parvin F, Ding, Kevin, Chen, Ling, Thomas, Denise, Wang, Jian, Lockhart, Albert C, Tan, Benjamin, Wang-Gillam, Andrea

獲取全文 獲取全文 獲取全文

Immunogenicity of influenza vaccination in patients with cancer 由 Waqar, Saiama N., Boehmer, Leigh, Morgensztern, Daniel, Wang-Gillam, Andrea, Sorscher, Steven, Lawrence, Steven, Gao, Feng, Guebert, Kalin, Williams, Kristina, Govindan, Ramaswamy

獲取全文 獲取全文 獲取全文

Concurrent HER or PI3K Inhibition Potentiates the Anti-tumor Effect of ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models 由 Jiang, Hongmei, Xu, Mai, Li, Lin, Grierson, Patrick, Dodhiawala, Paarth, Highkin, Maureen, Zhang, Daoxiang, Li, Qiong, Wang-Gillam, Andrea, Lim, Kian-Huat

獲取全文 獲取全文 獲取全文

Tumor-Stroma IL-1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, And Poor Prognosis In Pancreatic Cancer 由 Zhang, Daoxiang, Li, Lin, Jiang, Hongmei, Li, Qiong, Wang-Gillam, Andrea, Yu, Jinsheng, Head, Richard, Liu, Jingxia, Ruzinova, Marianna B., Lim, Kian-Huat

獲取全文 獲取全文 獲取全文

Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway 由 Lu, Yao, Xin, Dao, Guan, Lulu, Xu, Mengli, Yang, Yalan, Chen, Yu, Yang, Yuanyuan, Wang-Gillam, Andrea, Wang, Li, Zong, Shanggang, Wang, Feng

獲取全文 獲取全文 獲取全文

Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance In Pancreatic Ductal Adenocarcinoma 由 Zhang, Daoxiang, Li, Lin, Jiang, Hongmei, Knolhoff, Brett, Lockhart, Albert C., Wang-Gillam, Andrea, DeNardo, David G., Ruzinova, Marianna B., Lim, Kian-Huat

獲取全文 獲取全文 獲取全文

Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer 由 Amin, Manik, Desai, Monica, Trinkaus, Kathryn, Brown, Amberly, Wang-Gillam, Andrea, Tan, Benjamin, Picus, Joel, Sorscher, Steven, Highkin, Maureen, Lears, Kim, Lockhart, Albert C.

獲取全文 獲取全文 獲取全文

A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors 由 Wang-Gillam, Andrea, Tew, William P., Rothenberg, Mace L., Dupont, Jakob, Cooper, Wendy, Sternas, Lars, Buzenet, Giliane, Sosman, Jeffrey A., Spriggs, David R., Lockhart, Albert Craig

獲取全文 獲取全文 獲取全文

TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations 由 Dodhiawala, Paarth B., Khurana, Namrata, Zhang, Daoxiang, Cheng, Yi, Li, Lin, Wei, Qing, Seehra, Kuljeet, Jiang, Hongmei, Grierson, Patrick M., Wang-Gillam, Andrea, Lim, Kian-Huat

獲取全文 獲取全文 獲取全文

Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation 由 Hassanzadeh, Comron, Rudra, Soumon, Bommireddy, Ani, Hawkins, William G., Wang-Gillam, Andrea, Fields, Ryan C., Cai, Bin, Park, Justin, Green, Olga, Roach, Michael, Henke, Lauren, Kim, Hyun

獲取全文 獲取全文 獲取全文

CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T Cell Checkpoint Immunotherapy in Pancreatic Cancer Models 由 Zhu, Yu, Knolhoff, Brett L., Meyer, Melissa A., Nywening, Timothy M., West, Brian L., Luo, Jingqin, Wang-Gillam, Andrea, Goedegebuure, S Peter, Linehan, David C., DeNardo, David G.

獲取全文 獲取全文 獲取全文